Accessibility Menu
MariMed Stock Quote

MariMed (OTC: MRMD)

$0.14
(-8.8%)
-0.01
Price as of October 21, 2025, 3:52 p.m. ET

KEY DATA POINTS

Current Price
$0.14
Daily Change
(-8.8%) $0.01
Day's Range
$0.14 - $0.15
Previous Close
$0.14
Open
$0.14
Beta
0.56
Volume
1,291,734
Average Volume
1,595,689
Market Cap
61.4M
Market Cap / Employee
$0.16M
52wk Range
$0.07 - $0.23
Revenue
-
Gross Margin
0.21%
Dividend Yield
N/A
EPS
-$0.04
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

MariMed Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
MRMD-2.83%+5.06%+0.99%-61%
S&P+14.84%+96.04%+14.41%+182%

MariMed Company Info

MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$39.61M-2.0%
Gross Profit$8.64M-13.2%
Gross Margin21.81%-2.8%
Market Cap$26.86M-60.9%
Market Cap / Employee$0.03M0.0%
Employees83215.4%
Net Income-$1.27M22.5%
EBITDA$4.36M5.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$6.14M-39.8%
Accounts Receivable$7.73M-0.9%
Inventory38.824.7%

Liabilities

Q2 2025YOY Change
Long Term Debt$94.88M-4.3%
Short Term Debt$6.87M-6.8%

Ratios

Q2 2025YOY Change
Return On Assets-7.72%1.0%
Return On Invested Capital0.96%62.6%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$0.01M99.3%
Operating Free Cash Flow$0.30M-90.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.930.630.580.44-54.38%
Price to Sales0.410.280.230.17-61.11%
Price to Tangible Book Value1.921.291.321.35-16.60%
Enterprise Value to EBITDA36.9471.4364.0727.67-30.15%
Return on Equity-18.7%-18.3%-24.8%-24.4%22.72%
Total Debt$108.44M$107.47M$102.24M$101.75M-4.49%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.